Bloomberg TV’s Beyond Innovation

"Beyond Innovation" is a new TV series hosted by venture capitalist Anthony Lacavera and experienced tech journalist Michael Bancroft. This series reaches beyond the business-savvy viewer and engages general consumers with a window into the technologies informing today's global conversation. From the U.S. and Europe to Asia and Australia, this show will span the globe in search of the best and brightest innovations poised to change the way we live and do business.

Ultrasonic Eye Therapy with Opharmic Technology

Over 250 million people a year are affected by eye disease, and common treatment plans involve painful eye injections. Opharmic Technology has created new ultrasound technology that can noninvasively get patients the drugs they need without the needles. Langston Suen Founder & CEO talks to Anthony Lacavera about this new drug delivery method.

Smart Cities with Siemens

Siemens has developed MindSphere an IoT platform that can better connect and enable developers to put already existing data to use. Eric Chong, President and CEO of Siemens Hong Kong and Macao sat down with Anthony Lacavera to discuss how this concept helps make smart cities a reality.

Battling Diseases with BCT

Cancer continues to afflict millions of people every year. Paul Cheng, BCT International tells Anthony Lacavera how amino acids are playing a part in innovative cancer treatments that are treating human malignancies and auto-immune disorders.

IoT and Connected Devices with Arrow Electronics

With over 30 billion devices expected to be connected by 2020, IoT is all around us. Simon Yu, President of Asia-Pacific, Arrow Electronics tells Anthony Lacavera they're helping engineers fine tune projects, from idea to production.

Blockchain Innovations with CryptoBLK

Fast-tracking Fintech to commercialize blockchain technology. Anthony Lacavera speaks with CryptoBLK CEO Duncan Wong & HKSTP Chief Technology Officer George Tee about attracting top programming talent into the blockchain industry.

Cancer Immunotherapies with Arbele

Revolutionary new cancer treatments are on the horizon. Anthony Lacavera sat down with John Luk Founder and President of Arbele , and Albert Wong, CEO of HKSTP, to discuss the advancements in precision therapy and how new biotech will help us live longer than ever.

Contact Us